The current challenges for pancreas transplantation for diabetes mellitus

Pharmacological Research

Volumn 98, Issue , 2015, Pages 45-51

  Watson, Christopher J E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diabetes mellitus; Organ donation; Pancreas transplantation

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; BELATACEPT; CALCINEURIN INHIBITOR; DACLIZUMAB; EVEROLIMUS; HLA ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

DIABETES MELLITUS; DONOR SELECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE DEPLETION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SEGMENTAL PANCREAS TRANSPLANTATION; ANIMAL; PROCEDURES; RECURRENT DISEASE; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; RECURRENCE; TREATMENT OUTCOME;

EID: 84930763132     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.01.005     Document Type: Review

References (123)

1. Y. Idezuki, F.C. Goetz, F.K. Merkel, J.S. Najarian, W.D. Kelly, and R.C. Lillehei Experiences with pancreaticoduodenal allotransplantation Rev Fr Etud Clin Biol 13 10 1968 996 999
2. T.B. Dunn Life after pancreas transplantation: reversal of diabetic lesions Curr Opin Organ Transplant 19 1 2014 73 79
3. C. Gremizzi, A. Vergani, V. Paloschi, and A. Secchi Impact of pancreas transplantation on type 1 diabetes-related complications Curr Opin Organ Transplant 15 1 2010 119 123
4. M. Mauer, and P. Fioretto Pancreas transplantation and reversal of diabetic nephropathy lesions Med Clin North Am 97 1 2013 109 114
5. K. Waki, P.I. Terasaki, and T. Kadowaki Long-term pancreas allograft survival in simultaneous pancreas-kidney transplantation by era: UNOS registry analysis Diab Care 33 8 2010 1789 1791
6. J.S. Odorico, B. Voss, A. Munoz Del Rio, G. Leverson, Y.T. Becker, and J.D. Pirsch Kidney function after solitary pancreas transplantation Transplant Proc 40 2 2008 513 515
7. R.W.G. Gruessner, D.E.R. Sutherland, R. Kandaswamy, and A.C. Gruessner Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus Transplantation 85 1 2008 42 47
8. A.M. Shapiro, J.R. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, and G.L. Warnock Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 4 2000 230 238
9. B.J. Olack, C.J. Swanson, K.S. Flavin, D. Phelan, D.C. Brennan, and N.H. White Sensitization to HLA antigens in islet recipients with failing transplants Transplant Proc 29 4 1997 2268 2269
10. P.M. Campbell, P.A. Senior, A. Salam, K. Labranche, D.L. Bigam, and N.M. Kneteman High risk of sensitization after failed islet transplantation Am J Transplant 7 10 2007 2311 2317
11. B. Naziruddin, S. Wease, D. Stablein, F.B. Barton, T. Berney, and M.R. Rickels HLA class I sensitization in islet transplant recipients, report from the Collaborative Islet Transplant Registry Cell Transplant 21 5 2012 901 908
12. A.C. Gruessner, and D.E.R. Sutherland Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) Clin Transplant 2008 45 56
13. B.A. Kiberd, and T. Larson Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: a theoretical analysis Transplantation 70 7 2000 1121 1127
14. R.W.G. Gruessner, D.E.R. Sutherland, and A.C. Gruessner Mortality assessment for pancreas transplants Am J Transplant 4 12 2004 2018 2026
15. D. van Dellen, J. Worthington, O.M. Mitu-Pretorian, A. Ghazanfar, B. Forgacs, and R. Pararajasingam Mortality in diabetes: pancreas transplantation is associated with significant survival benefit Nephrol Dial Transplant 28 5 2013 1315 1322
16. A.C. Wiseman, E. Huang, M. Kamgar, and S. Bunnapradist The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes Nephrol Dial Transplant 28 4 2013 1047 1058
17. J.M. Smith, S.W. Biggins, D.G. Haselby, W.R. Kim, J. Wedd, and K. Lamb Kidney, pancreas and liver allocation and distribution in the United States Am J Transplant 12 12 2012 3191 3212
18. R.J. Johnson, S.V. Fuggle, L. Mumford, J.A. Bradley, J.L. Forsythe, C.J. Rudge Kidney Advisory Group of NHS Blood and Transplant A New UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys Transplantation 89 4 2010 387 394
19. A. Hudson, L. Bradbury, R. Johnson, S. Fuggle, J. Shaw, and J. Casey The UK pancreas allocation scheme for whole organ and islet transplantation Am J Transplant 2015 15
20. NHS Blood and Transplant. Organ donation and transplantation annual activity report 2013/14. NHS Blood and Transplant. Available from: http://nhsbtmediaservices.blob.core.windows.net/organ-donation-assets/pdfs/activity-report-2013-14.pdf [accessed 26.01.15].
21. R. Kandaswamy, P.G. Stock, M.A. Skeans, S.K. Gustafson, E.F. Sleeman, and J.L. Wainright OPTN/SRTR 2011 Annual Data Report: pancreas Am J Transplant 13 Suppl. 1 2013 47 72
22. M.S. Sampaio, N. Poommipanit, Y.W. Cho, T. Shah, and S. Bunnapradist Transplantation with pancreas after living donor kidney vs. living donor kidney alone in type 1 diabetes mellitus recipients Clin Transplant 24 6 2010 812 820
23. A.C. Wiseman Pancreas transplant options for patients with type 1 diabetes mellitus and chronic kidney disease: simultaneous pancreas kidney or pancreas after kidney? Curr Opin Organ Transplant 17 1 2012 80 86
24. N. Poommipanit, M.S. Sampaio, Y. Cho, B. Young, T. Shah, and P.-T. Pham Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database Transplantation 89 12 2010 1496 1503
25. B.Y. Young, J. Gill, E. Huang, S.K. Takemoto, B. Anastasi, and T. Shah Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database Clin J Am Soc Nephrol 4 4 2009 845 852
26. J.P. Lindahl, A. Hartmann, R. Horneland, H. Holdaas, A.V. Reisaeter, and K. Midtvedt Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease Diabetologia 56 6 2013 1364 1371
27. E. Huang, A. Wiseman, S. Okumura, H.-T. Kuo, and S. Bunnapradist Outcomes of preemptive kidney with or without subsequent pancreas transplant compared with preemptive simultaneous pancreas/kidney transplantation Transplantation 92 10 2011 1115 1122
28. J.F. Reynoso, C.E. Gruessner, D.E.R. Sutherland, and R.W.G. Gruessner Short- and long-term outcome for living pancreas donors J Hepatobiliary Pancreat Surg 17 2 2010 92 96
29. D.E.R. Sutherland, D. Radosevich, R. Gruessner, A. Gruessner, and R. Kandaswamy Pushing the envelope: living donor pancreas transplantation Curr Opin Organ Transplant 17 1 2012 106 115
30. E. Benedetti, T. Dunn, M.G. Massad, V. Raofi, A. Bartholomew, and R.W. Gruessner Successful living related simultaneous pancreas-kidney transplant between identical twins Transplantation 67 6 1999 915 918
31. R.W.G. Gruessner, A. Pugliese, H.K. Reijonen, S. Gruessner, T. Jie, and C. Desai Development of diabetes mellitus in living pancreas donors and recipients Expert Rev 7 4 2011 543 551
32. D. Cantarovich, A. Murat, M. Krempf, J. Paineau, and J.P. Soulillou Simultaneous pancreas and kidney transplantation in a type II (non-insulin-dependent) diabetic uremic patient requiring pregraft insulin therapy Transplant Proc 22 2 1990 662
33. A.C. Gruessner, and D.E. Sutherland Analyses of pancreas transplant outcomes for United States cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) Clin Transplant 1999 51 69
34. G. Orlando, R.J. Stratta, and J. Light Pancreas transplantation for type 2 diabetes mellitus Curr Opin Organ Transplant 16 1 2011 110 115
35. A.K. Israni, M.A. Skeans, S.K. Gustafson, M.A. Schnitzler, J.L. Wainright, and R.J. Carrico OPTN/SRTR 2012 Annual Data Report: pancreas Am J Transplant 14 Suppl. 1 2014 45 68
36. G.A. Wilson, G.L. Bumgardner, M.L. Henry, E.A. Elkhammas, W. Qiu, and E.A. Davies Decreased graft survival rate in obese pancreas/kidney recipients Transplant Proc 27 6 1995 3106 3107
37. J.R. Scalea, and M. Cooper Surgical strategies for type II diabetes Transplant Rev 26 3 2012 177 182
38. M. Porubsky, J.A. Powelson, D.J. Selzer, M.A. Mujtaba, T. Taber, and K.L. Carnes Pancreas transplantation after bariatric surgery Clin Transplant 26 1 2012 E1 E6
39. R.J. Johnson, L.L. Bradbury, K. Martin, J. Neuberger, and U.K.T. Registry Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry Transplantation 97 Suppl. 1 2014 S1 S27
40. A.C. Gruessner 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR) Rev Diabet Stud 8 1 2011 6 16
41. Organ Procurement and Transplantation Network. Deceased donors recovered in the U.S. by Donor Age. Available from: http://optn.transplant.hrsa.gov/converge/latestData/rptData.asp [accessed 05.01.15].
42. D.A. Axelrod, R.S. Sung, K.H. Meyer, R.A. Wolfe, and D.B. Kaufman Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization Am J Transplant 10 4 2010 837 845
43. E.B. Finger, D.M. Radosevich, T.B. Dunn, S. Chinnakotla, D.E.R. Sutherland, and A.J. Matas A composite risk model for predicting technical failure in pancreas transplantation Am J Transplant 13 7 2013 1840 1849
44. T. Ito, and M. Gotoh Report from the Japan Registry of Pancreas Transplantation (2000-2012): outcomes of pancreas transplantation from marginal donors Clin Transplant 2013 53 61
45. H.G. Illanes, C.M. Quarin, R. Maurette, N.G. Sanchez, L. Reniero, and D.H. Casadei Use of small donors (<28 kg) for pancreas transplantation Transplant Proc 41 6 2009 2199 2201
46. P.R. Salvalaggio, D.B. Davies, L.A. Fernandez, and D.B. Kaufman Outcomes of pancreas transplantation in the United States using cardiac-death donors Am J Transplant 6 5 Pt 1 2006 1059 1065
47. M.S. Qureshi, C.J. Callaghan, J.A. Bradley, C.J.E. Watson, and G.J. Pettigrew Outcomes of simultaneous pancreas-kidney transplantation from brain-dead and controlled circulatory death donors Br J Surg 99 6 2012 831 838
48. J.J. Blok, J. Ringers, A.F. Schaapherder, J. Dubbeld, A.G. Baranski, and J.W. de Fijter Report of the first five DCDD pancreas transplants within the Eurotransplant region; excellent results with prolonged first warm ischemia times Transpl Int 26 4 2013 e31 e33
49. A.S.R. Muthusamy, L. Mumford, A. Hudson, S.V. Fuggle, and P.J. Friend Pancreas transplantation from donors after circulatory death from the United Kingdom Am J Transplant 12 8 2012 2150 2156
50. A.C. Farney, R.P. Singh, M.H. Hines, J. Rogers, E.L. Hartmann, and A. Reeves-Daniel Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support J Am Coll Surg 206 5 2008 1028 1037 [discussion 1037]
51. A.J. Butler, L.V. Randle, and C.J. Watson Normothermic regional perfusion for donation after circulatory death without prior heparinization Transplantation 97 12 2014 1272 1278
52. T. Berney, and P.R.V. Johnson Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation Transplantation 90 3 2010 238 243
53. M.D. Stegall, P.G. Dean, R. Sung, M.K. Guidinger, M.A. McBride, and C. Sommers The rationale for the new deceased donor pancreas allocation schema Transplantation 83 9 2007 1156 1161
54. G. Tyden Status of pancreatic transplantation with enteric drainage: 30 years world experience Transplant Proc 30 2 1998 244 245
55. J.P. Squifflet, R.W.G. Gruessner, and D.E.R. Sutherland The history of pancreas transplantation: past, present and future Acta Chir Belg 108 3 2008 367 378
56. R.W.G. Gruessner, and A.C. Gruessner The current state of pancreas transplantation Nat Rev Endocrinol 9 9 2013 555 562
57. K.S. Reddy, T.D. Johnston, D. Karounas, and D. Ranjan Hospital charges following simultaneous kidney - pancreas transplantation: enteric drainage versus bladder drainage Clin Transplant 14 4 Pt 2 2000 375 379
58. M.J. Mazur, D.J. Rea, M.D. Griffin, T.S. Larson, M. Prieto, and J.M. Gloor Decline in native renal function early after bladder-drained pancreas transplantation alone Transplantation 77 6 2004 844 849
59. C. Jimenez-Romero, A. Manrique, J.C. Meneu, F. Cambra, A. Andres, and J.M. Morales Compative study of bladder versus enteric drainage in pancreas transplantation Transplant Proc 41 6 2009 2466 2468
60. C. Jimenez-Romero, A. Manrique, J.M. Morales, R.M. Lopez, E. Morales, and F. Cambra Conversion from bladder to enteric drainage for complications after pancreas transplantation Transplant Proc 41 6 2009 2469 2471
61. H. Shokouh-Amiri, J.M. Zakhary, and G.B. Zibari A novel technique of portal-endocrine and gastric-exocrine drainage in pancreatic transplantation J Am Coll Surg 212 4 2011 730 738 [discussion 738-739]
62. G. Gunasekaran, A. Wee, J. Rabets, C. Winans, and V. Krishnamurthi Duodenoduodenostomy in pancreas transplantation Clin Transplant 26 4 2012 550 557
63. M.M. Linhares, R.I. Beron, A.M. Gonzalez, C. Tarazona, A. Salzedas, and E. Rangel Duodenum-stomach anastomosis: a new technique for exocrine drainage in pancreas transplantation J Gastrointest Surg 16 5 2012 1072 1075
64. A.C. Gruessner, and D.E. Sutherland Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003 Clin Transplant 2003 21 51
65. J. Rogers, A.C. Farney, G. Orlando, U. Farooq, Y. Al-Shraideh, and R.J. Stratta Pancreas transplantation with portal venous drainage with an emphasis on technical aspects Clin Transplant 28 1 2014 16 26
66. R.Y. Calne Paratopic segmental pancreas grafting: a technique with portal venous drainage Lancet 1 8377 1984 595 597
67. A. Carpentier, B.W. Patterson, K.D. Uffelman, A. Giacca, M. Vranic, and M.S. Cattral The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism Diabetes 50 6 2001 1402 1413
68. K. Bouzakri, H.K.R. Karlsson, H. Vestergaard, S. Madsbad, E. Christiansen, and J.R. Zierath IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients Diabetes 55 3 2006 785 791
69. M. Stadler, C. Anderwald, G. Pacini, S. Zbyn, M. Promintzer-Schifferl, and M. Mandl Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver Diabetes 59 1 2010 215 218
70. M. Stadler, A. Storka, E.A. Theuer, M. Krebs, E. Vojtassakova, and P. Nowotny Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations Clin Endocrinol 72 6 2010 763 769
71. P. Fiorina, E. La Rocca, M. Venturini, F. Minicucci, I. Fermo, and R. Paroni Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes Diabetes 50 3 2001 496 501
72. P. Fiorina, E. La Rocca, E. Astorri, G. Lucignani, C. Rossetti, and F. Fazio Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients Diab Care 23 12 2000 1804 1810
73. A. Secchi, R. Caldara, E. La Rocca, P. Fiorina, and V. Di Carlo Cardiovascular disease and neoplasms after pancreas transplantation Lancet 352 9121 1998 65 [author reply 66]
74. E. La Rocca, P. Fiorina, E. Astorri, C. Rossetti, G. Lucignani, and F. Fazio Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients Cell Transplant 9 6 2000 929 932
75. F. Folli, V. Guzzi, L. Perego, D.K. Coletta, G. Finzi, and C. Placidi Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation PLoS ONE 5 3 2010 e9923
76. G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, and T. Canu Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study J Am Coll Cardiol 46 6 2005 1085 1092
77. J. Frystyk, R.A. Ritzel, J. Maubach, M. Busing, R. Luck, and J. Klempnauer Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis J Clin Endocrinol Metab 93 5 2008 1758 1766
78. P. Petruzzo, L. Badet, N. Lefrancois, C. Berthillot, S.B. Dorel, and X. Martin Metabolic consequences of pancreatic systemic or portal venous drainage in simultaneous pancreas-kidney transplant recipients Diabet Med 23 6 2006 654 659
79. B. Philosophe, A.C. Farney, E.J. Schweitzer, J.O. Colonna, B.E. Jarrell, and V. Krishnamurthi Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study Ann Surg 234 5 2001 689 696
80. R.J. Stratta, M.H. Shokouh-Amiri, M.F. Egidi, H.P. Grewal, A.T. Kizilisik, and N. Nezakatgoo A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage Ann Surg 233 6 2001 740 751
81. R.J. Stratta, A.O. Gaber, M.H. Shokouh-Amiri, K.S. Reddy, M.F. Egidi, and H.P. Grewal A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation Surgery 127 2 2000 217 226
82. G. Sundkvist, G. Tyden, F.A. Karlsson, and J. Bolinder Islet autoimmunity before and after pancreas transplantation in patients with type I diabetes mellitus Diabetologia 41 12 1998 1532 1533
83. S.V. Niederhaus, D.B. Kaufman, and J.S. Odorico Induction therapy in pancreas transplantation Transpl Int 26 7 2013 704 714
84. M. Zachariah, A. Gregg, J. Schold, J. Magliocca, and L.K. Kayler Alemtuzumab induction in simultaneous pancreas and kidney transplantation Clin Transplant 27 5 2013 693 700
85. W.J. Hao, H.T. Zong, Y.S. Cui, and Y. Zhang The efficacy and safety of alemtuzumab and daclizumab versus antithymocyte globulin during organ transplantation: a meta-analysis Transplant Proc 44 10 2012 2955 2960
86. R.Y. Calne, K. Rolles, D.J. White, S. Thiru, D.B. Evans, and P. McMaster Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers Lancet 2 8151 1979 1033 1036
87. R.W. Gruessner, D.E. Sutherland, M.B. Drangstveit, M. West, and A.C. Gruessner Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation Transplant Proc 30 2 1998 518 520
88. E. Letavernier, M.N. Pe'raldi, A. Pariente, E. Morelon, and C. Legendre Proteinuria following a switch from calcineurin inhibitors to sirolimus Transplantation 80 9 2005 1198 1203
89. E. Letavernier, and C. Legendre mToR inhibitors-induced proteinuria: mechanisms, significance, and management Transplant Rev 22 2 2008 125 130
90. F. Diekmann, A. Andres, and F. Oppenheimer mTOR inhibitor-associated proteinuria in kidney transplant recipients Transplant Rev 26 1 2012 27 29
91. D.P. Cina, T. Onay, A. Paltoo, C. Li, Y. Maezawa, and J. De Arteaga Inhibition of MTOR disrupts autophagic flux in podocytes J Am Soc Nephrol 23 3 2012 412 420
92. M. Roland, P. Gatault, C. Doute, M. Buchler, A. Al-Najjar, and C. Barbet Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation Transpl Int 21 6 2008 523 530
93. O. Johnston, C.L. Rose, A.C. Webster, and J.S. Gill Sirolimus is associated with new-onset diabetes in kidney transplant recipients J Am Soc Nephrol 19 7 2008 1411 1418
94. P. Girman, K. Lipar, R. Koznarova, P. Boucek, J. Kriz, and M. Kocik Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens Transplant Proc 42 6 2010 1999 2002
95. R.W.G. Gruessner, and A.C. Gruessner Pancreas transplant alone: a procedure coming of age Diab Care 36 8 2013 2440 2447
96. V.C. McAlister, Z. Gao, K. Peltekian, J. Domingues, K. Mahalati, and A.S. MacDonald Sirolimus-tacrolimus combination immunosuppression Lancet 355 9201 2000 376 377
97. A. Kahl, M. Oppert, A. Muller, U. Settmacher, J. Lepenies, and J. Klupp Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation Transplant Proc 34 6 2002 2253 2255
98. G. Laham, S. Sleiman, G. Soler Pujol, C. Diaz, M. Davalos, and A. Vilches Conversion to sirolimus allows preservation of renal function in kidney and kidney-pancreas allograft recipients Transplant Proc 42 1 2010 309 313
99. J. Rogers, E.E. Ashcraft, O.E. Emovon, G.M. Baillie, D.J. Taber, and R.G. Marques Long-term outcome of sirolimus rescue in kidney-pancreas transplantation Transplantation 78 4 2004 619 622
100. T. van Gelder, C.G. ter Meulen, R. Hene, W. Weimar, and A. Hoitsma Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil Transplantation 75 6 2003 788 791
101. J.M. Campistol, J.W. de Fijter, S.M. Flechner, A. Langone, E. Morelon, and E. Stockfleth mTOR inhibitor-associated dermatologic and mucosal problems Clin Transplant 24 2 2010 149 156
102. J. Hasskarl Everolimus Recent Results Cancer Res Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 201 2014 373 392
103. L. Feldmeyer, G.F. Hofbauer, T. Boni, L.E. French, and J. Hafner Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing Br J Dermatol 166 2 2012 422 424
104. C.P. Larsen, T.C. Pearson, A.B. Adams, P. Tso, N. Shirasugi, and E. Strobert Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties Am J Transplant 5 3 2005 443 453
105. A. Durrbach, J.M. Pestana, T. Pearson, F. Vincenti, V.D. Garcia, and J. Campistol A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study) Am J Transplant 10 3 2010 547 557
106. F. Vincenti, B. Charpentier, Y. Vanrenterghem, L. Rostaing, B. Bresnahan, and P. Darji A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) Am J Transplant 10 3 2010 535 546
107. M.A. Mujtaba, A.A. Sharfuddin, T. Taber, J. Chen, C.L. Phillips, and M. Goble Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients Am J Transplant 14 11 2014 2657 2661
108. A.D. Kirk, A. Guasch, H. Xu, J. Cheeseman, S.I. Mead, and A. Ghali Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors Am J Transplant 14 5 2014 1142 1151
109. A. Loupy, C. Lefaucheur, D. Vernerey, C. Prugger, J.P. Duong van Huyen, and N. Mooney Complement-binding anti-HLA antibodies and kidney-allograft survival N Engl J Med 369 13 2013 1215 1226
110. S. Mittal, S.L. Page, P.J. Friend, E.J. Sharples, and S.V. Fuggle De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure Am J Transplant 14 7 2014 1664 1671
111. D. Cantarovich, S. De Amicis, A. Akl, A. Devys, F. Vistoli, and G. Karam Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome Am J Transplant 11 12 2011 2737 2746
112. R.P. Pelletier, P.K. Hennessy, P.W. Adams, A.M. VanBuskirk, R.M. Ferguson, and C.G. Orosz Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation Am J Transplant 2 2 2002 134 141
113. J.E. Cooper, J. Gralla, L. Cagle, R. Goldberg, L. Chan, and A.C. Wiseman Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes Transplantation 91 10 2011 1103 1109
114. A. Dorling, I. Rebollo-Mesa, R. Hilton, J.L. Peacock, R. Vaughan, and L. Gardner Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial Trials 15 2014 30
115. H.E. Feucht, H. Schneeberger, G. Hillebrand, K. Burkhardt, M. Weiss, and G. Riethmuller Capillary deposition of C4d complement fragment and early renal graft loss Kidney Int 43 6 1993 1333 1338
116. H. de Kort, R.B. Munivenkatappa, S.P. Berger, M. Eikmans, A. van der Wal, and E.J. de Koning Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients Am J Transplant 10 7 2010 1660 1667
117. C.B. Drachenberg, J.R. Torrealba, B.J. Nankivell, E.B. Rangel, I.M. Bajema, and D.U. Kim Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema Am J Transplant 11 9 2011 1792 1802
118. C. Pihoker, L.K. Gilliam, C.S. Hampe, and A. Lernmark Autoantibodies in diabetes Diabetes 54 Suppl. 2 2005 S52 S61
119. S. Braghi, E. Bonifacio, A. Secchi, V. Di Carlo, G. Pozza, and E. Bosi Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes Diabetes 49 2 2000 218 224
120. G. Tyden, F.P. Reinholt, G. Sundkvist, and J. Bolinder Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts N Engl J Med 335 12 1996 860 863
121. G.W. Burke 3rd, F. Vendrame, A. Pileggi, G. Ciancio, H. Reijonen, and A. Pugliese Recurrence of autoimmunity following pancreas transplantation Curr Diab Rep 11 5 2011 413 419
122. F. Vendrame, A. Pileggi, E. Laughlin, G. Allende, A. Martin-Pagola, and R.D. Molano Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells Diabetes 59 4 2010 947 957
123. T. Lohmann, T. Klemm, F. Geissler, D. Uhlmann, S. Ludwig, and J. Hauss Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation Transplant Proc 34 6 2002 2249 2250